Lähteenvuo notes that while more research is called for, drugs like Ozempic may offer hope to those burdened by addiction, ...

Around 2,500 patients who used liraglutide, marketed as Victoza and Saxenda ... READ ALSO: Ozempic: 8 common side effects of ...

A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists semaglutide and liraglutide, which are used for treating diabetes and obesity, ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

and liraglutide with a 22% lower risk. The risk of hospitalization when using GLP-1-agonists was lower than when using ...

Semaglutide and liraglutide are associated with reduced AUD and SUD-related ... according to the 2023 National Survey on Drug ...

Use of a second drug in the same class of GLP-1 medications, liraglutide (Victoza), was linked to a 28% reduction in ...

Hims & Hers Health, a telehealth company, is planning to offer a generic version of Novo Nordisk's diabetes drug, liraglutide ...

The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...

Denmark-based Novo Nordisk teased some new details about a potential Ozempic successor during a call with investors on Tuesday. Sales of the company’s current blockbuster weight loss drug, Wegovy, ...

On November 5, the US Food and Drug Administration (FDA ... The affected drugs are semaglutide (Ozempic, Rybelsus, Wegovy); liraglutide (Saxenda, Victoza); and the dual glucose-dependent ...

Telehealth platform Hims & Hers will begin offering a generic version of liraglutide, a GLP-1 weight loss drug, to its customers in 2025, Quartz reported Nov. 4.